Literature DB >> 25908098

A study of T₁ relaxation time as a measure of liver fibrosis and the influence of confounding histological factors.

Caroline L Hoad1,2, Naaventhan Palaniyappan2, Philip Kaye2,3, Yulia Chernova2, Martin W James2, Carolyn Costigan1, Andrew Austin4, Luca Marciani2, Penny A Gowland1, Indra N Guha2, Susan T Francis1, Guruprasad P Aithal2.   

Abstract

Liver biopsy is the standard test for the assessment of fibrosis in liver tissue of patients with chronic liver disease. Recent studies have used a non-invasive measure of T1 relaxation time to estimate the degree of fibrosis in a single slice of the liver. Here, we extend this work to measure T1 of the whole liver and investigate the effects of additional histological factors such as steatosis, inflammation and iron accumulation on the relationship between liver T1 and fibrosis. We prospectively enrolled patients who had previously undergone liver biopsy to have MR scans. A non-breath-holding, fast scanning protocol was used to acquire MR relaxation time data (T1 and T2*), and blood serum was used to determine the enhanced liver fibrosis (ELF) score. Areas under the receiver operator curves (AUROCs) for T1 to detect advanced fibrosis and cirrhosis were derived in a training cohort and then validated in a second cohort. Combining the cohorts, the influence of various histology factors on liver T1 relaxation time was investigated. The AUROCs (95% confidence interval (CI)) for detecting advanced fibrosis (F ≥ 3) and cirrhosis (F = 4) for the training cohort were 0.81 (0.65-0.96) and 0.92 (0.81-1.0) respectively (p < 0.01). Inflammation and iron accumulation were shown to significantly alter T1 in opposing directions in the absence of advanced fibrosis; inflammation increasing T1 and iron decreasing T1. A decision tree model was developed to allow the assessment of early liver disease based on relaxation times and ELF, and to screen for the need for biopsy. T1 relaxation time increases with advanced fibrosis in liver patients, but is also influenced by iron accumulation and inflammation. Together with ELF, relaxation time measures provide a marker to stratify patients with suspected liver disease for biopsy.
Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  fibrosis; hepatobiliary; inflammation; iron; other applications; relaxometry

Mesh:

Substances:

Year:  2015        PMID: 25908098     DOI: 10.1002/nbm.3299

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  39 in total

1.  Influence of fat deposition on T1 mapping of the pancreas: evaluation by dual-flip-angle MR imaging with and without fat suppression.

Authors:  Mayumi Higashi; Masahiro Tanabe; Munemasa Okada; Matakazu Furukawa; Etsushi Iida; Katsuyoshi Ito
Journal:  Radiol Med       Date:  2019-09-27       Impact factor: 3.469

2.  Association of Liver Fibrosis With Cardiovascular Diseases in the General Population: The Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Mohammad R Ostovaneh; Bharath Ambale-Venkatesh; Tomoki Fuji; Hooman Bakhshi; Ravi Shah; Venkatesh L Murthy; Russell P Tracy; Eliseo Guallar; Colin O Wu; David A Bluemke; João A C Lima
Journal:  Circ Cardiovasc Imaging       Date:  2018-03       Impact factor: 7.792

3.  Evaluation of variable flip angle, MOLLI, SASHA, and IR-SNAPSHOT pulse sequences for T1 relaxometry and extracellular volume imaging of the pancreas and liver.

Authors:  Temel Tirkes; Xuandong Zhao; Chen Lin; Alex Jordan Stuckey; Liang Li; Shivriman Giri; Dominik Nickel
Journal:  MAGMA       Date:  2019-06-04       Impact factor: 2.310

4.  Quantitative assessment of disease severity of primary sclerosing cholangitis with T1 mapping and extracellular volume imaging.

Authors:  Sehnaz Evrimler; Jordan K Swensson; Vijay S Are; Temel Tirkes; Raj Vuppalanchi; Fatih Akisik
Journal:  Abdom Radiol (NY)       Date:  2020-11-01

Review 5.  Imaging of Hepatic Fibrosis.

Authors:  Rishi Philip Mathew; Sudhakar Kundapur Venkatesh
Journal:  Curr Gastroenterol Rep       Date:  2018-08-29

6.  T1 -corrected quantitative chemical shift-encoded MRI.

Authors:  Xiaoke Wang; Timothy J Colgan; Louis A Hinshaw; Nathan T Roberts; Leah C Henze Bancroft; Gavin Hamilton; Diego Hernando; Scott B Reeder
Journal:  Magn Reson Med       Date:  2019-11-14       Impact factor: 4.668

7.  Imaging biomarkers of diffuse liver disease: current status.

Authors:  Bachir Taouli; Filipe Caseiro Alves
Journal:  Abdom Radiol (NY)       Date:  2020-06-25

8.  Native T1 mapping compared to ultrasound elastography for staging and monitoring liver fibrosis: an animal study of repeatability, reproducibility, and accuracy.

Authors:  Jinning Li; Huanhuan Liu; Caiyuan Zhang; Shuyan Yang; Yanshu Wang; Weibo Chen; Xin Li; Dengbin Wang
Journal:  Eur Radiol       Date:  2019-07-23       Impact factor: 5.315

9.  MR fingerprinting with simultaneous T1, T2, and fat signal fraction estimation with integrated B0 correction reduces bias in water T1 and T2 estimates.

Authors:  Jason Ostenson; Bruce M Damon; E Brian Welch
Journal:  Magn Reson Imaging       Date:  2019-03-23       Impact factor: 2.546

10.  T2 relaxation time is related to liver fibrosis severity.

Authors:  Alexander R Guimaraes; Luiz Siqueira; Ritika Uppal; Jamu Alford; Bryan C Fuchs; Suguru Yamada; Kenneth Tanabe; Raymond T Chung; Gregory Lauwers; Michael L Chew; Giles W Boland; Duhyant V Sahani; Mark Vangel; Peter F Hahn; Peter Caravan
Journal:  Quant Imaging Med Surg       Date:  2016-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.